These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [On the effect of a new synthetic inhibitor of the fibrinolytic system]. Fischer M; Pavlu C Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440 [No Abstract] [Full Text] [Related]
7. Effect of an inhibitor of fibrinolysis upon the intravascular clearance of fibrin monomer in dogs. Pratt HW; Celander DR J Am Osteopath Assoc; 1970 Jun; 69(10):1049-50. PubMed ID: 5201432 [No Abstract] [Full Text] [Related]
8. Inhibition of plasminogen binding to fibrin by alpha2-plasmin inhibitor. Moroi M; Aoki N Thromb Res; 1977 Jun; 10(6):851-6. PubMed ID: 70081 [No Abstract] [Full Text] [Related]
9. Effect of epsilon-aminocaproylamino acids on fibrin formation. Bruzgo I; Midura-Nowaczek K; Bruzgo M; Kaczyńska J; Roszkowska-Jakimiec W Acta Pol Pharm; 2006; 63(2):149-52. PubMed ID: 17514879 [TBL] [Abstract][Full Text] [Related]
10. A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening. Kostka B; Para J; Sikora J Blood Coagul Fibrinolysis; 2007 Oct; 18(7):611-8. PubMed ID: 17890947 [TBL] [Abstract][Full Text] [Related]
11. Glycosylation of thrombin activatable fibrinolysis inhibitor: why is it so important? Biscetti F Circ Res; 2008 Feb; 102(3):278-9. PubMed ID: 18276924 [No Abstract] [Full Text] [Related]
12. Potent fibrinolysis inhibitor discovered by shape and electrostatic complementarity to the drug tranexamic acid. Boström J; Grant JA; Fjellström O; Thelin A; Gustafsson D J Med Chem; 2013 Apr; 56(8):3273-80. PubMed ID: 23521080 [TBL] [Abstract][Full Text] [Related]
13. alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study. Hevessy Z; Patthy A; Kárpáti L; Muszbek L Thromb Res; 2000 Aug; 99(4):399-406. PubMed ID: 10963790 [No Abstract] [Full Text] [Related]
14. Influence of dipeptide derivatives of S-substituted cysteines on the time of fibrinolysis. Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K Rocz Akad Med Bialymst; 1996; 41(2):412-6. PubMed ID: 9020554 [TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding. Steinmetzer T; Pilgram O; Wenzel BM; Wiedemeyer SJA J Med Chem; 2020 Feb; 63(4):1445-1472. PubMed ID: 31658420 [TBL] [Abstract][Full Text] [Related]